Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 45Breast Neoplasms 45Colorectal Neoplasms 28Prostatic Neoplasms 27Lung Neoplasms 26Pancreatic Neoplasms 18Carcinoma, Non-Small-Cell Lung 12Motor Activity 11Head and Neck Neoplasms 10Urinary Bladder Neoplasms 9Ovarian Neoplasms 9Hematologic Neoplasms 9Stomach Neoplasms 8Neoplasm Metastasis 8Anxiety Disorders 8Uterine Cervical Neoplasms 7Multiple Myeloma 6Hematopoietic and Lymphatic System Neoplasm 6Esophageal Neoplasms 6Anatomic Stage I Breast Cancer AJCC v8 6Advanced Cancer 6Triple Negative Breast Neoplasms 5Smoking Cessation 5Rectal Neoplasms 5Radiodermatitis 5Gastrointestinal Neoplasms 5Colonic Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Sarcoma 4Melanoma 4

Interventions

proxalutamide 1Transurethral Resection of Prostate 1Transurethral Resection of Bladder 1Therapeutics 1Tamsulosin 1Standard of Care 1Microspheres 1Lycopene 1Levofloxacin 1Dutasteride 1Dexmedetomidine 1Catheters, Indwelling 1Biopsy 1Amyloid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Prostatic Hyperplasia × Standard of Care × Clear all
NCT04446429 2021-12-10

Anti-Androgen Treatment for COVID-19

Applied Biology, Inc.

Phase NA Completed
268 enrolled 8 charts
Genitourinary

COVID-19, Alopecia, Prostatic Hyperplasia, Prostatic Neoplasms, Severe Acute Respiratory Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡